Top Markets
Coin of the day
Vaxil Bio Ltd. Vaxil Bio Ltd.

Vaxil Bio Ltd.

VXL
주식 순위 #39496
Vaxil Bio Ltd. is a biotechnology firm dedicated to discovering and developing... Vaxil Bio Ltd. is a biotechnology firm dedicated to discovering and developing innovative therapeutic agents. Its foundation lies in a unique signal peptide-based platform, which it leverages to address critical health challenges, specifically infectious diseases and various cancers. The company's primary therapeutic candidate, ImMucin, has successfully advanced through Phase I/II clinical trials as a potential treatment for multiple myeloma. Beyond ImMucin, Vaxil Bio is actively developing a vaccine/treatment for tuberculosis, as well as a vaccine targeting coronavirus (COVID-19). Strategic alliances bolster its research efforts; Vaxil Bio collaborates with The Tel Aviv Sourasky Medical Center on a research initiative to create a peptide-based COVID-19 vaccine. Furthermore, it holds a Cooperative Research and Development Agreement with the U.S. Army Medical Research Institute of Infectious Diseases to assess CorVax's efficacy in preventing COVID-19 in murine models. Established in 2006, the company's operations are based in Toronto, Canada.
주가
$0.1174299
마지막 동기화: 2026-08-13
시가총액
$467.84K
변동 (1일)
-8.57%
변동 (1년)
1.38%
국가
CA
거래 Vaxil Bio Ltd. (VXL)

카테고리

Vaxil Bio Ltd. (VXL)의 주가 이력
최고 종가: $0.13 (2026-08-01 기준)

최저 종가: $137.64 (2010-03-01 기준)
Vaxil Bio Ltd.의 주가 이력 (2010 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 24.66%
2025 -72.61%
2024 -24.06%
2023 -28.26%
2022 -76.68%
2021 -41.79%
2020 258.87%
2019 16.10%
2018 -52.29%
2017 -41.76%
2016 16.83%
2015 -19.78%
2014 -67.07%
2013 -46.95%
2012 -44.33%
2011 -48.81%
2010 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$517.18 32.51%
US
$857.76 31.47%
NL
$731.17 7.05%
CH
$1.07K -6.40%
KR
$257.40 13.71%
BE